JPRN-UMIN000030757已完成未知
Comprehensive gene analysis for the specimen of pancreatic cancer obtained by EUS-FNA - Comprehensive gene analysis for the specimen of pancreatic cancer
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
The collection rate of EUS-FNB specimens suitable for comprehensive cancer panels using deep sequencing was 93.6%. Mutation in p53 and Smad4 were positively and negatively associated, respectively, with disease control at the initial evaluation. The median time to progression in 15 patients with p53 and without Smad4 mutations was 182.0 days; whereas, it was 92.5 days in other 10 patients; this difference was significant (p = 0.020).
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Presence of interveneous vesseles in the puncture line during EUS-FNA 2. High risk of bleeding 3. Difficulty of performing EUS 4. Without informed consent 5. Deemed ineligible
研究者
相似试验
尚未招募
不适用
Collection of Sequential Samples From Patients With Malignant Myeloid Hemopathy for the Study of Treatment ResistanceHematologic CancerNCT05602168Institut Paoli-Calmettes400
已完成
不适用
Prospective Comprehensive Molecular Profiling In Neuroendocrine TumorsNeuroendocrine TumorsPancreatic Neuroendocrine TumorsNCT02586844University Health Network, Toronto13
终止
不适用
Detection of Tumor DNA in Blood Samples From Patients With Early Stage Cancer and "Healthy Controls"Neoplasms, Non-hematologic - Stage I-IIINCT03071809Lexent Bio, Inc.5
Unknown
不适用
Detection of Tumor DNA in Blood Samples From Cancer PatientsTumorsCancerNCT02288754Lexent Bio, Inc.500
招募中
不适用
MRD Application in Colorectal Cancer PatientsSurgeryChemotherapy EffectColorectal CancerNCT06028516Shandong First Medical University200